Fulgent Genetics completes $56.9 million acquisition of two labs
Tweet Send to a Friend
Fulgent Genetics Inc. (NASDAQ: FLGT) completed its acquisition of Bako Diagnostics and StrataDx for approximately $56.9 million in cash, the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
